Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chary-Valckenaere, I.
Right arrow Articles by Jaulhac, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chary-Valckenaere, I.
Right arrow Articles by Jaulhac, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 36, 945-949, Copyright © 1997 by British Society for Rheumatology

ORIGINAL PAPERS

Seroreactivity to Borrelia burgdorferi antigens in early rheumatoid arthritis: a case-control study

I Chary-Valckenaere, F Guillemin, J Pourel, F Schiele, R Heller and B Jaulhac
Department of Rheumatology, URA CNRS 1288, Centre Hospitalier Universitaire de Nancy, France.

This study investigates the seroreactivity to Borrelia burgdorferi antigens of patients suffering from rheumatoid arthritis (RA) for < 5 yr. Subjects were matched with controls for age, sex and area of residence in order to minimize the risk of differential exposure to B. burgdorferi. A total of 57 pairs were tested by immunofluorescence assay (IFA) and Western blotting. Only two RA patients showed positive IFA results, and another was positive by Western blot analysis. No significant difference in Lyme seropositivity was detected between cases and controls using either serological test. Furthermore, no significant difference in antibody response was observed to specific or non-specific proteins (e.g. Osp C, 93 kDa protein, flagellin, heat shock proteins). These results do not support the previous suggestions that B. burgdorferi may be involved in the aetiology of RA, or that RA favours the production of antibodies that cross-react with B. burgdorferi proteins.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CVIHome page
Y.-F. Hsieh, H.-W. Liu, T.-C. Hsu, J. C.-C. Wei, C.-M. Shih, P. J. Krause, and G. J. Tsay
Serum Reactivity against Borrelia burgdorferi OspA in Patients with Rheumatoid Arthritis
Clin. Vaccine Immunol., November 1, 2007; 14(11): 1437 - 1441.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
B. Jaulhac, R. Heller, F. X. Limbach, Y. Hansmann, D. Lipsker, H. Monteil, J. Sibilia, and Y. Piémont
Direct Molecular Typing of Borrelia burgdorferi Sensu Lato Species in Synovial Samples from Patients with Lyme Arthritis
J. Clin. Microbiol., May 1, 2000; 38(5): 1895 - 1900.
[Abstract] [Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.